FDA Requests Laid-Off Employees Back to Help with Tobacco Cases, Enforcement Capacity Severely Weakened

Apr.17.2025
FDA Requests Laid-Off Employees Back to Help with Tobacco Cases, Enforcement Capacity Severely Weakened
FDA staff cuts impact tobacco enforcement: HHS layoffs jeopardize fines on retailers, potentially hindering tobacco law enforcement.

Key points:

FDA Layoffs Affect Tobacco Enforcement: The US Department of Health and Human Services (HHS) laid off approximately 10,000 employees on April 1, including the department responsible for fining retailers for violations under the FDA. This move may result in a slowdown in tobacco enforcement efforts.

FDA has requested that some laid-off employees temporarily return to work to help with unfinished cases. About 20 employees have agreed to return until their official departure on June 2nd.

 

Weakened regulatory ability: Layoffs have weakened the FDA's ability to enforce penalties on non-compliant retailers, experts worry this may undermine the recent decline in tobacco use rates.

Fines Income Affected: The disbandment of the Civil Fines Office could impact FDA's fines income, leading to a reduction in federal revenue. This office is also a key tool in cracking down on the illegal distribution of e-cigarettes.

Reasons for HHS Staff Reduction: The Department of Health and Human Services stated that the layoffs are primarily focused on administrative and redundant positions. However, FDA officials believe that this move severely undermines tobacco enforcement capabilities and could lead to looser retailer behavior.


According to a report from POLITICO on April 14th, the U.S. Food and Drug Administration (FDA) has recently asked some tobacco enforcement agents who were previously laid off to temporarily return to work in order to address the halt in regulatory capacity caused by significant manpower reductions.

 

According to four federal health officials, the layoffs were carried out by the Secretary of the Department of Health and Human Services (HHS), Robert F. Kennedy Jr., on April 1st, resulting in the dismissal of around 10,000 employees, including those responsible for imposing civil fines on non-compliant retailers at the FDA. This department was previously able to handle over a hundred cases of illegal sales per week, focusing on punishing stores that sell cigarettes and e-cigarettes to minors.

 

Informed officials have stated that the recent layoffs have crippled the FDA's main enforcement tool against tobacco retailers, leading to a halt in related case processing. In order to maintain enforcement continuity as much as possible, senior FDA officials recently invited some laid-off employees to return on a short-term basis to assist with processing before their formal departure date on June 2nd. As of last Friday, more than 20 people have agreed to return to work. It is reported that some employees are concerned that if they refuse to return, they may lose their severance package.

 

Kennedy's cost-cutting measures have not affected the team responsible for handling warning letters and comprehensive bans, but there is a lack of a team responsible for enforcing fines and sales bans. Former FDA Center for Tobacco Products Director Mitch Zeller stated that this move essentially allows retailers to "flout the law," severely undermining policies aimed at controlling youth tobacco use.

 

In 2024, the tobacco use rate among American teenagers hit a new low in 25 years, causing concern among health experts. They worry that without continued federal enforcement support, this achievement could face the risk of reversal. At the same time, the Civil Monetary Penalty Office is also a key tool in combating the illegal distribution of e-cigarettes.

 

Currently, it is not clear why the Department of Health and Human Services (HHS) is focusing on dismantling the office responsible for civil penalties, which is a part of the U.S. Food and Drug Administration's (FDA) tobacco enforcement system known as the Division of Business Operations. The entire operational costs of the FDA Center for Tobacco Products are covered by user fees paid by the industry, with no involvement of federal budgets. This means that layoffs will not result in any savings for taxpayers, but could potentially reduce the Treasury's revenue from fines imposed by the FDA.

 

After layoffs, the FDA has not yet announced its future plan for enforcement restructuring. According to internal sources, some senior officials at the FDA's Center for Tobacco Products are still trying to fully restore its functions, but some employees have been told that returning to work in the short term does not necessarily mean they will be rehired in the future.

 

Department of Health and Human Services spokesperson Andrew Nixon stated in a declaration that laid-off employees may be required to work for a short period before their official departure date (June 2nd), with the aim of "minimizing disruptions to agency functions and ensuring a smooth transition.

 

Kennedy stated in a previous interview with the media that all positions that were cut were either administrative or considered redundant. He emphasized that the relevant work would be taken over by other programs through integration. Internal officials at the FDA have stated that these cuts have effectively paralyzed their tobacco enforcement actions. The agency's enforcement process consists of three stages: first-time offenders receive a warning letter, repeated violations result in civil penalties, and the most serious violations lead to a ban on all tobacco sales.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Pennsylvania Vape Directory Law Survives Court Challenge From Nova Distro and Others Amid Similar Rulings Across States
Pennsylvania Vape Directory Law Survives Court Challenge From Nova Distro and Others Amid Similar Rulings Across States
A U.S. federal court upheld Pennsylvania's vape directory law on October 14, rejecting a challenge brought by Nova Distro, 101 Distributors and companies operating Tobacco Hut retail stores. Court records show that vaping accounts for about 60% of Tobacco Hut's profits and that the chain held approximately $2 million in inventory potentially subject to seizure under the law as of June 2. Pennsylvania began enforcement on October 19. The ruling follows similar appellate decisions in other states, even as new research shows that unlisted vaping products continue to account for substantial sales in states with established directories.
Regulations
Oct.22
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology (NYSE: RLX) has been removed from the FTSE All-World Index, effective September 21. FTSE Russell records show RLX was already part of its global equity index universe by 2022, when its American depositary receipts were classified as China Large Cap securities. Trading volume rose to about 44.77 million shares on September 18, roughly 23 times the previous session's volume. RLX reported RMB1.0105 billion in second-quarter revenue, up 14.8% year over year, with international operations contributing 68.5%. The company also acquired a 51% stake in one of Western Europe's largest distributors of next-generation smoke-free and FMCG products in July.
Sep.22
Reynolds Puts Nearly 183,000 U.S. Contracted Outlets Under Age-Verification Rules, Covering 94% of Volume — Can It Shift an Unauthorized Vape Market?
Reynolds Puts Nearly 183,000 U.S. Contracted Outlets Under Age-Verification Rules, Covering 94% of Volume — Can It Shift an Unauthorized Vape Market?
Reynolds American says nearly 183,000 U.S. retail outlets are under contract, with its Retail Marketing Plan Contract covering about 94% of company volume and requiring point-of-sale age verification. The company combines those contracts with We Card, TruAge, NACS-linked infrastructure and POS integration, while enhanced Vuse Pro retail rules add ID scanning, purchase limits and stronger underage-sales accountability. The initial Vuse Pro rollout targets about 50,000 stores. The system is taking shape as unauthorized vapor products remain dominant in parts of the U.S. market: a 2026 study estimated they accounted for 69.4% of tracked brick-and-mortar e-cigarette dollar sales in December 2025.
Special Report
Oct.15
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
The U.S. Food and Drug Administration (FDA) has named Jessica Zeller director of the Center for Tobacco Products' (CTP) Office of Compliance and Enforcement (OCE), effective November 1, 2026. Zeller, the office's inaugural deputy director, returns from medical device manufacturer Edwards Lifesciences with more than 20 years of regulatory and legal experience. The appointment follows CTP leadership changes and adjustments to tobacco regulation. Bret Koplow became permanent CTP director in September; the FDA revised enforcement priorities for unauthorized e-cigarettes and nicotine pouches in May and announced faster PMTA review procedures. On September 28, the agency said it would evaluate changes to the existing PMTA regulatory framework, including potential rulemaking to replace it.
FDA
Oct.20 by 2Firsts Perspectives
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
South Korea Constitutional Court Upholds Volume-Based E-Liquid Tax, With Challenged Rates at KRW 370 and KRW 628 per Milliliter
South Korea Constitutional Court Upholds Volume-Based E-Liquid Tax, With Challenged Rates at KRW 370 and KRW 628 per Milliliter
South Korea's Constitutional Court has upheld fixed taxes on nicotine-containing e-cigarette liquids based on solution volume, ruling that challenged provisions imposing KRW 370 per milliliter in individual consumption tax and KRW 628 per milliliter in tobacco consumption tax do not violate the Constitution. The cases stemmed from historical disputes involving importers that reported nicotine as being extracted from tobacco stems rather than leaves. South Korea has since broadened its tobacco definition to include synthetic nicotine, while current tax laws provide reduced rates for certain products not derived from tobacco.
Sep.18